Repaglinide
- Product NDC
- 72603-810
- 11-digit product format
- 726030810
- Labeler code
- 72603
- Product ID
- 72603-810_19426809-2230-4ebf-a29a-40e25326a943
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA207209
- Marketing category
- ANDA
- Marketing start
- 2025-04-08
- Substance
- REPAGLINIDE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Repaglinide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| REPAGLINIDE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 668Z8C33LU |
| Rxcui | 200256, 200257, 200258 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-810-01 | Repaglinide | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72603-810 | REPAGLINIDE TABLET [NORTHSTAR RXLLC] | 1 | Current NDC, 1 package rows | 20250412_7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-810-01 | 72603081001 | 100 TABLET in 1 BOTTLE (72603-810-01) | 100 tablet | 2025-04-08 | No | No | Historical |